Total Funding
$23M
Employee Range
11-50
Sibylla Biotech specializes in the development of small molecule folding interfering degraders (FIDs) that target diverse therapeutic areas. By harnessing the power of these innovative compounds, Sibylla aims to revolutionize treatments and improve patient outcomes across various diseases.
Sibylla Biotech data powered by:
Share
Sibylla Biotech data powered by:
Sibylla BiotechOverall Ranking
Regional Rank
Share
Loading...
In Western Europe
Top null%out of startups
Sibylla BiotechIndustry Rankings in
Healthtech
City Rank
Share
1st
In Trento
Top 20%out of 5 startups
National Rank
Share
16th
In Italy
Top 10%out of 172 startups
Regional Rank
Share
728th
In Western Europe
Top 16%out of 4551 startups
Sibylla BiotechSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Trento
Top 25%out of 4 startups
National Rank
Share
4th
In Italy
Top 6%out of 76 startups
Regional Rank
Share
282nd
In Western Europe
Top 17%out of 1726 startups
rankings by:
Sibylla BiotechSB Rank Evolution
Not enough data points to display the chart.
Sibylla BiotechstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro